Semnurpharma - Getting back to normalSemnurpharmaSemnurpharmaSemnurpharma

Getting back to normal

  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Our Culture
  • Partners
  • Chronic Back Pain
    • Chronic Back Pain
    • SP-102 (SEMDEXA™)
    • About our Studies
      • Phase 3 C.L.E.A.R.-2 Study
      • Phase 3 C.L.E.A.R. Study
      • Phase 2 Repeat Dose Study – SP102-03
      • Phase 1 PK/PD and Safety Study – SP-102
      • Pre-Clinical Study – SP-102
  • Science
    • Technology
    • Publications
    • Clinical Trials
  • Investors
    • Investor Overview
    • Presentation
    • News and Events
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
  • Join Our Team
  • Contact Us

News

07
Jan
Date January 7, 2018

Semnur Pharmaceuticals Begins Pivotal Phase 3 Trial For SP-102 In Patients With Lumbar Radicular Pain/Sciatica

SP-102 Granted Fast Track Designation From The FDA Semnur Pharmaceuticals Announces The Launch Of T...
Read More
Author [email protected]
26
Jun
Date June 26, 2017

Semnur Pharmaceuticals, Inc., Announces Successful Phase 1 / 2 Trial in Patients with Radicular Pain for Its Lead Product, SP-102

- Pharmacokinetic data supports previous preclinical results, demonstrating an extended product resi...
Read More
Author [email protected]
15
Aug
Date August 15, 2016

Scintilla Pharmaceuticals, Inc., a Subsidiary of Sorrento Therapeutics, Inc., to Acquire Semnur Pharmaceuticals, Inc. to Further Deepen its Pain Management Pipeline

SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Scintilla Pharmaceuticals, Inc. ("Scintilla"), a subsidiar...
Read More
Author [email protected]
16
May
Date May 16, 2014

TiE50 Awards Program 2014 Winners Includes Semnur Pharmaceuticals

Recognizing World's Most Enterprising Technology Startups TiE50 is TiE Silicon Valley’s premier an...
Read More
Author [email protected]
Previous page 1 2

 

  • Overview
  • Partners
  • Our Culture
  • Product
  • Publications
  • Join Our Team
  • Presentation
  • Contact Us

Connect, follow and have a conversation with us

  • 960 San Antonio Road, Palo Alto, CA, 94303
  • (650) 422-7515
  • [email protected]

Privacy Policy | Terms of Use | © 2026 All rights reserved.